Azelastine Hydrochloride Patent Expiration
Azelastine Hydrochloride is Used for relieving allergy symptoms such as nasal congestion, runny nose, sneezing, and itchy nose. It was first introduced by Norvium Bioscience Llc
Azelastine Hydrochloride Patents
Given below is the list of patents protecting Azelastine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Astepro | US8071073 | Compositions comprising azelastine and methods of use thereof | Jun 04, 2028 | Meda Pharms |
Astepro | US8071073 | Compositions comprising azelastine and methods of use thereof | Jun 04, 2028 | Viatris |
Astepro Allergy | US8071073 | Compositions comprising azelastine and methods of use thereof | Jun 04, 2028 | Bayer Hlthcare |
Children's Astepro Allergy | US8071073 | Compositions comprising azelastine and methods of use thereof | Jun 04, 2028 | Bayer Hlthcare |
Astepro | US8518919 | Compositions comprising azelastine and methods of use thereof | Nov 22, 2025 | Meda Pharms |
Astepro | US8518919 | Compositions comprising azelastine and methods of use thereof | Nov 22, 2025 | Viatris |
Astepro | US9919050 | Compositions comprising azelastine | Nov 22, 2025 | Viatris |
Astepro Allergy | US8518919 | Compositions comprising azelastine and methods of use thereof | Nov 22, 2025 | Bayer Hlthcare |
Astepro Allergy | US9919050 | Compositions comprising azelastine | Nov 22, 2025 | Bayer Hlthcare |
Children's Astepro Allergy | US8518919 | Compositions comprising azelastine and methods of use thereof | Nov 22, 2025 | Bayer Hlthcare |
Children's Astepro Allergy | US9919050 | Compositions comprising azelastine | Nov 22, 2025 | Bayer Hlthcare |
Azelastine Hydrochloride's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List